Cancer type |
Cell line |
EpCAM antibody |
EpCAMaptamer |
Pancreatic cancer |
PANC-1 |
++ |
++ |
ASPC-1 |
++ |
++ |
PANC-28 |
+ |
+ |
Breast cancer |
MDA-MB-231 |
++ |
++ |
MDA-MB-468 |
++ |
++ |
BT-474 |
+ |
+ |
SKBR3 |
++ |
++ |
Ovarian cancer |
OVCAR3 |
+ |
+ |
SKOV3 |
+ |
+ |
Hey |
+ |
+ |
Prostate cancer |
DU145 |
++ |
++ |
22RV1 |
+ |
+ |
VCap |
+ |
+ |
PC3 |
+ |
+ |
Colon cancer |
HT29 |
++ |
++ |
Epithelial cells |
293T |
++ |
++ |
HeLa |
+ |
+ |
Chronic myelogenous leukemia |
K562 |
++ |
++ |
Burkitt’s lymphoma |
CA46 |
- |
- |
Mantle Cell Lymphoma |
Jeko-1 |
- |
- |
Mantle Cell Lymphoma |
Maver-1 |
- |
- |
Acute Myeloid Leukemia |
HEL |
- |
- |
Histiocytic lymphoma |
U937 |
- |
- |
|
Note: “++” EpCAM overexpression, “+” EpCAM -positive,
“-” EpCAM-negative |
Table 1: Summary of EpCAM aptamer binding to differentiate cancer
cells. |